Izrael - hebrejščina - Ministry of Health

dexcel pharma technologies ltd - tramadol hydrochloride - טבליות בשחרור ממושך - tramadol hydrochloride 300 mg - tramadol - tramadol - treatment of moderate to severe pain.

Izrael - hebrejščina - Ministry of Health

dexcel pharma technologies ltd - olanzapine 5 mg - tablets - olanzapine - acute and maintenance treatment of schizophrenia. olanzapine is indicated for the management of the manifestations of psychotic disorders. olanzapine is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. prevention of recurrence in bipolar disorder: in patients whose manic episodes has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder: the combination of olanzapine with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

Izrael - hebrejščina - Ministry of Health

dexcel pharma technologies ltd - olanzapine 7.5 mg - tablets - olanzapine - acute and maintenance treatment of schizophrenia. olanzapine is indicated for the management of the manifestations of psychotic disorders. olanzapine is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. prevention of recurrence in bipolar disorder: in patients whose manic episodes has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder: the combination of olanzapine with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

Izrael - hebrejščina - Ministry of Health

dexcel pharma technologies ltd - olanzapine 10 mg - tablets - olanzapine - acute and maintenance treatment of schizophrenia. olanzapine is indicated for the management of the manifestations of psychotic disorders. olanzapine is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. prevention of recurrence in bipolar disorder: in patients whose manic episodes has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder : the combination of olanzapine with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

Izrael - hebrejščina - Ministry of Health

dexcel pharma technologies ltd - olanzapine 15 mg - tablets - olanzapine - acute and maintenance treatment of schizophrenia. olanzapine is indicated for the management of the manifestations of psychotic disorders. olanzapine is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. prevention of recurrence in bipolar disorder: in patients whose manic episodes has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder: the combination of olanzapine with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

Izrael - hebrejščina - Ministry of Health

dexcel pharma technologies ltd - olanzapine 20 mg - tablets - olanzapine - acute and maintenance treatment of schizophrenia. olanzapine is indicated for the management of the manifestations of psychotic disorders. olanzapine is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. prevention of recurrence in bipolar disorder: in patients whose manic episodes has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder: the combination of olanzapine with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

Izrael - hebrejščina - Ministry of Health

dexcel pharma technologies ltd - risperidone - טבליה - risperidone 1 mg - risperidone - risperidone - risperidex is indicated for the management of schizophrenia and the manifestations of psychotic disorders. the antipsychotic efficacy of risperdone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidex is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidex is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidex is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract

Izrael - hebrejščina - Ministry of Health

dexcel pharma technologies ltd - risperidone - קפליות - risperidone 2 mg - risperidone - risperidone - risperidex is indicated for the management of schizophrenia and the manifestations of psychotic disorders. the antipsychotic efficacy of risperdone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidex is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidex is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidex is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract

Izrael - hebrejščina - Ministry of Health

dexcel pharma technologies ltd - risperidone - טבליה - risperidone 3 mg - risperidone - risperidone - risperidex is indicated for the management of schizophrenia and the manifestations of psychotic disorders. the antipsychotic efficacy of risperdone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidex is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidex is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidex is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract

Izrael - hebrejščina - Ministry of Health

dexcel pharma technologies ltd - risperidone - קפליות - risperidone 4 mg - risperidone - risperidone - risperidex is indicated for the management of schizophrenia and the manifestations of psychotic disorders. the antipsychotic efficacy of risperdone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidex is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidex is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidex is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract